Sfoglia per Rivista HEPATOLOGY
A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and EMT
2012-01-01 Seok, J. Y.; Na, D. C.; Woo, H. G.; Roncalli, M.; Kwon, S. M.; Yoo, J. E.; Ahn, E. Y.; Kim, G. I.; Choi, J. S.; Kim, Y. B.; Park, Y. N.
A multistep assessment of human liver mitochondrial function through C-13-ketoisocaproate and C-13-octanoate breath tests
2000-01-01 Armuzzi, A; Grieco, A; Zocco, Ma; Miele, L; Di Campli, C; Candelli, M; Padalino, C; De Caro, S; Nista, E; De Lorenzo, A; Gasbarrini, G; Gasbarrini, A
A Phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of non-oncogenic RTKs
2017-01-01 Fan, Y; Arechederra, M; Richelme, S; Daian, F; Novello, C; Calderaro, J; Di Tommaso, L; Morcrette, G; Rebouissou, S; Donadon, M; Morenghi, E; Zucman-Rossi, J; Roncalli, M; Dono, R; Maina, F.
A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis
2007-01-01 Oertelt, S.; Rieger, R.; Selmi, C.; Invernizzi, P.; Ansari, A. A.; Coppel, R. L.; Podda, M.; Leung, P. S.; Gershwin, M. E.
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach
2021-01-01 Cristoferi, Laura; Calvaruso, Vincenza; Overi, Diletta; Vigano, Mauro; Rigamonti, Cristina; Degasperi, Elisabetta; Cardinale, Vincenzo; Labanca, Sara; Zucchini, Nicola; Fichera, Anna; Di Marco, Vito; Leutner, Monica; Venere, Rosanna; Picciotto, Antonino; Luca, Martina; Mulinacci, Giacomo; Palermo, Andrea; Gerussi, Alessio; D'Amato, Daphne; O'Donnell, Sarah Elisabeth; Cerini, Federica; De Benedittis, Carla; Malinverno, Federica; Ronca, Vincenzo; Mancuso, Clara; Cazzagon, Nora; Ciaccio, Antonio; Barisani, Donatella; Marzioni, Marco; Floreani, Annarosa; Alvaro, Domenico; Gaudio, Eugenio; Invernizzi, Pietro; Carpino, Guido; Nardi, Alessandra; Carbone, Marco
Accurate assessment of cardiac function and myocardial fibrosis in liver cirrhosis by contrast-enhanced cardiac magnetic resonance
2007-01-01 Merli, Manuela; Riggio, Oliviero; Ridola, Lorenzo; G., Lombardi; Pinto, Giorgio; Attili, Adolfo Francesco; Francone, Marco; Catalano, Carlo
Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy
1999-01-01 Torzilli, G.; Minagawa, M.; Takayama, T.; Inoue, K.; Hui, A. M.; Kubota, K.; Ohtomo, K.; Makuuchi, M.
Age Might Confound the Impact of the Transmembrane 6 Superfamily Member 2 E167K Polymorphism on Hepatic Fibrosis in Hepatitis C Virus-Infected Patients REPLY
2016-01-01 Romeo, S.; Aghemo, A.; Berg, T.; Stickel, F.; Valenti, L.
Aminopyrine and methacetin breath tests in HCV-related chronic liver disease
2001-01-01 Candelli, M; Armuzzi, A; Zocco, Ma; Bartolozzi, F; Grieco, A; Nista, Ec; Pignataro, G; Miele, L; Gasbarrini, G; Gasbarrini, A
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis
2008-01-01 Aghemo, A.; Ronzoni, L.; Rumi, M.; Monico, S.; Colancecco, A.; Grillo, P.; Viganò, M.; Cappellini, M. D.; Colombo, M.
AN ANTI-MICA/B MONOCLONAL ANTIBODY SUPPORTS ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TO INTRAHEPATIC CHOLANGIOCARCINOMA CELLS.
2019-01-01 Oliviero, B; Donadon, M; Soldani, C; Franceschini, B; Torzilli, G; Maestri, M; Varchetta, S; Mele, D; Pedrazzoli, P; Mondelli, Mu; Mantovani, S
ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA
2019-01-01 Raggi, C; Fiaccadori, K; Pastore, M; Correnti, M; Piombanti, B; Forti, E; Navari, N; Abbadessa, G; Hall, T; Destro, A; Di Tommaso, L; Roncalli, M; Meng, F; Glaser, Ss; Rovida, E; Peraldo-Neia, C; Olaizola, P; Banales, Jm; Gerussi, A; Elvevi, A; Busset, Mdd; Bhoori, S; Mazzaferro, V; Alpini, G; Marra, F; Invernizzi, P
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.
2011-01-01 Omar, Ha; Chou, Cc; Berman-Booty, Ld; Ma, Y; Hung, Jh; Wang, D; Kogure, T; Patel, T; Terracciano, L; Muthusamy, N; Byrd, Jc; Kulp, Sk; Chen, Cs
Apotopes and the biliary specificity of primary biliary cirrhosis
2009-01-01 Lleo De Nalda, A.; Selmi, C.; Invernizzi, P.; Podda, M.; Coppel, R. L.; Mackay, I. R.; Gores, G. J.; Ansari, A. A.; Van de Water, J.; Gershwin, M. E.
B cell depletion therapy exacerbates murine primary biliary cirrhosis
2011-01-01 Dhirapong, A; Lleo, A; Yang, G-X; Tsuneyama, K; Dunn, R; Kehry, M; Packard, Ta; Cambier, Jc; Liu, Ft; Lindor, K; Coppel, Rl; (co-first author), Ansari AA and Gershwin ME.
B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury
2018-01-01 Faggioli, F.; Palagano, E.; Di Tommaso, L.; Donadon, M.; Marrella, V.; Recordati, C.; Mantero, S.; Villa, A.; Vezzoni, P.; Cassani, B.
Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis
2010-01-01 Lleo, A; Bowlus, Lc; Yang, Qx; Invernizzi, P; Podda, M; Van de Water, J; Ansari, Aa; Coppel, Rl; Worman, Hj; Gores GJ and Gershwin ME,
Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells
2008-01-01 Shimoda, S.; Harada, K.; Niiro, H.; Yoshizumi, T.; Soejima, Y.; Taketomi, A.; Maehara, Y.; Tsuneyama, K.; Nakamura, M.; Komori, A.; Migita, K.; Nakanuma, Y.; Ishibashi, H.; Selmi, C.; Gershwin, M. E.
Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure
2013-01-01 Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf
Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy
2017-01-01 Di Maio, Vc; Barbaliscia, S; Teti, E; Lenci, I; Aragri, M; Polilli, E; Gianserra, L; Palitti, Vp; Bruzzone, B; Paolucci, S; Coppola, N; Ruggiero, T; Pollicino, T; Niero, F; Micheli, V; Di Biagio, A; Bertoli, A; Sticchi, L; Maida, I; Francioso, S; Foroghi, L; Calvaruso, V; Morisco, F; Lleo, A; Ciancio, A; Maserati, R; Brancaccio, G; Puoti, M; Toniutto, P; Vullo, V; Aghemo, A; Cariti, G; Bonora, S; Babudieri, S; Gubertini, Ga; Rendina, M; Pellicelli, Am; Sangiovanni, V; Ciaccio, A; Taliani, G; Raimondo, G; Craxi, A; Pasquazzi, C; Sarmati, L; Parruti, G; Angelico, M; Andreoni, M; Cento, V; Perno, Cf; Ceccherini-Silberstein, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and EMT | 1-gen-2012 | Seok, J. Y.; Na, D. C.; Woo, H. G.; Roncalli, M.; Kwon, S. M.; Yoo, J. E.; Ahn, E. Y.; Kim, G. I.; Choi, J. S.; Kim, Y. B.; Park, Y. N. | |
| A multistep assessment of human liver mitochondrial function through C-13-ketoisocaproate and C-13-octanoate breath tests | 1-gen-2000 | Armuzzi, A; Grieco, A; Zocco, Ma; Miele, L; Di Campli, C; Candelli, M; Padalino, C; De Caro, S; Nista, E; De Lorenzo, A; Gasbarrini, G; Gasbarrini, A | |
| A Phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of non-oncogenic RTKs | 1-gen-2017 | Fan, Y; Arechederra, M; Richelme, S; Daian, F; Novello, C; Calderaro, J; Di Tommaso, L; Morcrette, G; Rebouissou, S; Donadon, M; Morenghi, E; Zucman-Rossi, J; Roncalli, M; Dono, R; Maina, F. | |
| A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis | 1-gen-2007 | Oertelt, S.; Rieger, R.; Selmi, C.; Invernizzi, P.; Ansari, A. A.; Coppel, R. L.; Podda, M.; Leung, P. S.; Gershwin, M. E. | |
| Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach | 1-gen-2021 | Cristoferi, Laura; Calvaruso, Vincenza; Overi, Diletta; Vigano, Mauro; Rigamonti, Cristina; Degasperi, Elisabetta; Cardinale, Vincenzo; Labanca, Sara; Zucchini, Nicola; Fichera, Anna; Di Marco, Vito; Leutner, Monica; Venere, Rosanna; Picciotto, Antonino; Luca, Martina; Mulinacci, Giacomo; Palermo, Andrea; Gerussi, Alessio; D'Amato, Daphne; O'Donnell, Sarah Elisabeth; Cerini, Federica; De Benedittis, Carla; Malinverno, Federica; Ronca, Vincenzo; Mancuso, Clara; Cazzagon, Nora; Ciaccio, Antonio; Barisani, Donatella; Marzioni, Marco; Floreani, Annarosa; Alvaro, Domenico; Gaudio, Eugenio; Invernizzi, Pietro; Carpino, Guido; Nardi, Alessandra; Carbone, Marco | |
| Accurate assessment of cardiac function and myocardial fibrosis in liver cirrhosis by contrast-enhanced cardiac magnetic resonance | 1-gen-2007 | Merli, Manuela; Riggio, Oliviero; Ridola, Lorenzo; G., Lombardi; Pinto, Giorgio; Attili, Adolfo Francesco; Francone, Marco; Catalano, Carlo | |
| Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy | 1-gen-1999 | Torzilli, G.; Minagawa, M.; Takayama, T.; Inoue, K.; Hui, A. M.; Kubota, K.; Ohtomo, K.; Makuuchi, M. | |
| Age Might Confound the Impact of the Transmembrane 6 Superfamily Member 2 E167K Polymorphism on Hepatic Fibrosis in Hepatitis C Virus-Infected Patients REPLY | 1-gen-2016 | Romeo, S.; Aghemo, A.; Berg, T.; Stickel, F.; Valenti, L. | |
| Aminopyrine and methacetin breath tests in HCV-related chronic liver disease | 1-gen-2001 | Candelli, M; Armuzzi, A; Zocco, Ma; Bartolozzi, F; Grieco, A; Nista, Ec; Pignataro, G; Miele, L; Gasbarrini, G; Gasbarrini, A | |
| Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis | 1-gen-2008 | Aghemo, A.; Ronzoni, L.; Rumi, M.; Monico, S.; Colancecco, A.; Grillo, P.; Viganò, M.; Cappellini, M. D.; Colombo, M. | |
| AN ANTI-MICA/B MONOCLONAL ANTIBODY SUPPORTS ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TO INTRAHEPATIC CHOLANGIOCARCINOMA CELLS. | 1-gen-2019 | Oliviero, B; Donadon, M; Soldani, C; Franceschini, B; Torzilli, G; Maestri, M; Varchetta, S; Mele, D; Pedrazzoli, P; Mondelli, Mu; Mantovani, S | |
| ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA | 1-gen-2019 | Raggi, C; Fiaccadori, K; Pastore, M; Correnti, M; Piombanti, B; Forti, E; Navari, N; Abbadessa, G; Hall, T; Destro, A; Di Tommaso, L; Roncalli, M; Meng, F; Glaser, Ss; Rovida, E; Peraldo-Neia, C; Olaizola, P; Banales, Jm; Gerussi, A; Elvevi, A; Busset, Mdd; Bhoori, S; Mazzaferro, V; Alpini, G; Marra, F; Invernizzi, P | |
| Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma. | 1-gen-2011 | Omar, Ha; Chou, Cc; Berman-Booty, Ld; Ma, Y; Hung, Jh; Wang, D; Kogure, T; Patel, T; Terracciano, L; Muthusamy, N; Byrd, Jc; Kulp, Sk; Chen, Cs | |
| Apotopes and the biliary specificity of primary biliary cirrhosis | 1-gen-2009 | Lleo De Nalda, A.; Selmi, C.; Invernizzi, P.; Podda, M.; Coppel, R. L.; Mackay, I. R.; Gores, G. J.; Ansari, A. A.; Van de Water, J.; Gershwin, M. E. | |
| B cell depletion therapy exacerbates murine primary biliary cirrhosis | 1-gen-2011 | Dhirapong, A; Lleo, A; Yang, G-X; Tsuneyama, K; Dunn, R; Kehry, M; Packard, Ta; Cambier, Jc; Liu, Ft; Lindor, K; Coppel, Rl; (co-first author), Ansari AA and Gershwin ME. | |
| B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury | 1-gen-2018 | Faggioli, F.; Palagano, E.; Di Tommaso, L.; Donadon, M.; Marrella, V.; Recordati, C.; Mantero, S.; Villa, A.; Vezzoni, P.; Cassani, B. | |
| Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis | 1-gen-2010 | Lleo, A; Bowlus, Lc; Yang, Qx; Invernizzi, P; Podda, M; Van de Water, J; Ansari, Aa; Coppel, Rl; Worman, Hj; Gores GJ and Gershwin ME, | |
| Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells | 1-gen-2008 | Shimoda, S.; Harada, K.; Niiro, H.; Yoshizumi, T.; Soejima, Y.; Taketomi, A.; Maehara, Y.; Tsuneyama, K.; Nakamura, M.; Komori, A.; Migita, K.; Nakanuma, Y.; Ishibashi, H.; Selmi, C.; Gershwin, M. E. | |
| Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure | 1-gen-2013 | Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf | |
| Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy | 1-gen-2017 | Di Maio, Vc; Barbaliscia, S; Teti, E; Lenci, I; Aragri, M; Polilli, E; Gianserra, L; Palitti, Vp; Bruzzone, B; Paolucci, S; Coppola, N; Ruggiero, T; Pollicino, T; Niero, F; Micheli, V; Di Biagio, A; Bertoli, A; Sticchi, L; Maida, I; Francioso, S; Foroghi, L; Calvaruso, V; Morisco, F; Lleo, A; Ciancio, A; Maserati, R; Brancaccio, G; Puoti, M; Toniutto, P; Vullo, V; Aghemo, A; Cariti, G; Bonora, S; Babudieri, S; Gubertini, Ga; Rendina, M; Pellicelli, Am; Sangiovanni, V; Ciaccio, A; Taliani, G; Raimondo, G; Craxi, A; Pasquazzi, C; Sarmati, L; Parruti, G; Angelico, M; Andreoni, M; Cento, V; Perno, Cf; Ceccherini-Silberstein, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile